| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.2 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.2 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.2 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.038 | 0.2 |